Cox Christopher Nixon sold ANRO

February 6, 2024 · Form 4 insider transaction

Cox Christopher Nixon sold 1,250,000 shares of Alto Neuroscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
1,250,000
Price
$0.00
Total value
N/A
RoleDirector
SecuritySeries B Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateFebruary 6, 2024
Filing dateFebruary 7, 2024
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date.; The shares are directly held by Lightswitch Capital Fund I, L.P. ("Lightswitch Capital"), of which Lightswitch Capital GP, LLC ("Lightswitch GP") is the sole general partner and exercises voting and investment power over these shares. The Reporting Person is the Chief Executive Officer of Lightswitch GP and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.

View the original Form 4 on SEC EDGAR